Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep;21(9):1582-8.
doi: 10.3201/eid2109.150570.

Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance

Gayle Langley, John Besser, Martha Iwamoto, Fernanda C Lessa, Alicia Cronquist, Tami H Skoff, Sandra Chaves, Dave Boxrud, Robert W Pinner, Lee H Harrison

Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance

Gayle Langley et al. Emerg Infect Dis. 2015 Sep.

Abstract

The Centers for Disease Control and Prevention Emerging Infections Program (EIP) network conducts population-based surveillance for pathogens of public health importance. Central to obtaining estimates of disease burden and tracking microbiological characteristics of these infections is accurate laboratory detection of pathogens. The use of culture-independent diagnostic tests (CIDTs) in clinical settings presents both opportunities and challenges to EIP surveillance. Because CIDTs offer better sensitivity than culture and are relatively easy to perform, their use could potentially improve estimates of disease burden. However, changes in clinical testing practices, use of tests with different sensitivities and specificities, and changes to case definitions make it challenging to monitor trends. Isolates are still needed for performing strain typing, antimicrobial resistance testing, and identifying other molecular characteristics of organisms. In this article, we outline current and future EIP activities to address issues associated with adoption of CIDTs, which may apply to other public health surveillance.

Keywords: EIP; Emerging Infections Program; antigen-based testing; culture-independent diagnostics; molecular testing; surveillance.

PubMed Disclaimer

References

    1. Millman A, Reed C, Daily Kirley P, Aragon D, Meek J, Farley M, et al. Impact of changes in diagnostic testing on estimated influenza-associated hospitalization rates in the Influenza Hospitalization Surveillance Network (FluSurv-NET): United States, 2003–2013. Presented at: 63rd EIS Conference; 2014. Apr 28– May 1; Atlanta, Georgia, USA.
    1. US Food and Drug Administration. Respiratory multiplex panels. Medical devices 2013–4 [cited 2014 Dec 16]. http://www.accessdata.fda.gov/scripts/cdrh/devicesatfda/index.cfm?sia=1
    1. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–34. 10.1056/NEJMoa1408913 - DOI - PMC - PubMed
    1. Faulkner AE, Skoff TH, Clark TA, Martin SW. Evolution of pertussis diagnostic testing in the U.S.: 1995–2009. Presented at: Council of State and Territorial Epidemiologists Annual Conference; 2011 Jun 12–16; Pittsburgh, Pennsylvania, USA. Atlanta: The Council; 2011.
    1. Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KW. Real-world performance of a microarray-based rapid diagnostic for gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis. 2015;81:4–8. 10.1016/j.diagmicrobio.2014.09.025 - DOI - PubMed

MeSH terms

LinkOut - more resources